miRNA (2 pre)

[{"image":"https://icons.cdn.biorender.com/w75xh75/5e7cad82aa46cb0028b0e4eb/5e7cad2faa46cb0028b0e4d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7cad82aa46cb0028b0e4eb/5e7cad2faa46cb0028b0e4d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7cad82aa46cb0028b0e4ea/5e7cad2faa46cb0028b0e4d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7cad82aa46cb0028b0e4ea/5e7cad2faa46cb0028b0e4d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7cad82aa46cb0028b0e4e9/5e7cad2faa46cb0028b0e4d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7cad82aa46cb0028b0e4e9/5e7cad2faa46cb0028b0e4d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7cad82aa46cb0028b0e4e8/5e7cad2faa46cb0028b0e4d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7cad82aa46cb0028b0e4e8/5e7cad2faa46cb0028b0e4d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7cad82aa46cb0028b0e4e7/5e7cad2faa46cb0028b0e4d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7cad82aa46cb0028b0e4e7/5e7cad2faa46cb0028b0e4d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7cad82aa46cb0028b0e4e6/5e7cad2faa46cb0028b0e4d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7cad82aa46cb0028b0e4e6/5e7cad2faa46cb0028b0e4d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7cad82aa46cb0028b0e4e5/5e7cad2faa46cb0028b0e4d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7cad82aa46cb0028b0e4e5/5e7cad2faa46cb0028b0e4d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7cad82aa46cb0028b0e4e4/5e7cad2faa46cb0028b0e4d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7cad82aa46cb0028b0e4e4/5e7cad2faa46cb0028b0e4d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7cad82aa46cb0028b0e4e3/5e7cad2faa46cb0028b0e4d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7cad82aa46cb0028b0e4e3/5e7cad2faa46cb0028b0e4d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7cad82aa46cb0028b0e4e2/5e7cad2faa46cb0028b0e4d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7cad82aa46cb0028b0e4e2/5e7cad2faa46cb0028b0e4d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7cad82aa46cb0028b0e4e1/5e7cad2faa46cb0028b0e4d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7cad82aa46cb0028b0e4e1/5e7cad2faa46cb0028b0e4d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7cad82aa46cb0028b0e4e0/5e7cad2faa46cb0028b0e4d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7cad82aa46cb0028b0e4e0/5e7cad2faa46cb0028b0e4d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7cad82aa46cb0028b0e4df/5e7cad2faa46cb0028b0e4d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7cad82aa46cb0028b0e4df/5e7cad2faa46cb0028b0e4d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7cad82aa46cb0028b0e4de/5e7cad2faa46cb0028b0e4d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7cad82aa46cb0028b0e4de/5e7cad2faa46cb0028b0e4d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7cad82aa46cb0028b0e4dd/5e7cad2faa46cb0028b0e4d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7cad82aa46cb0028b0e4dd/5e7cad2faa46cb0028b0e4d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7cad82aa46cb0028b0e4dc/5e7cad2faa46cb0028b0e4d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7cad82aa46cb0028b0e4dc/5e7cad2faa46cb0028b0e4d7.png"}]